Skip to content

Clinical trials

Phase 1 Anemia, Sickle Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 1 Country / region: United States Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20043
20052
20062
20071
20092
20105
20113
20123
20134
20144
201510
20164
20173
20185
20196
20207
20216
20224
20235
20244
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated14
Recruiting12
Active, not recruiting5
Withdrawn4
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)10
Pfizer5
St. Jude Children's Research Hospital5
City of Hope Medical Center4
Emory University4
Fulcrum Therapeutics3
Global Blood Therapeutics3
National Institutes of Health Clinical Center (CC)3
University of Mississippi Medical Center3
Baylor College of Medicine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell98
beta-Thalassemia8
Hematologic Diseases6
Thalassemia6
Hemoglobinopathies5
Acute Chest Syndrome4
Hypertension, Pulmonary4
Vaso-Occlusive Crises4
Anemia3
Hemoglobin SC Disease3

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.